Ironwood Pharmaceuticals Inc reports results for the quarter ended in September - Earnings Summary

Ironwood Pharmaceuticals

03/11/2022 13:33

* Ironwood Pharmaceuticals Inc  IRWD.OQ  reported quarterly
adjusted earnings of 28 cents​​ per share for the quarter ended
in September. The mean expectation of five analysts for the
quarter was for earnings of 27 cents per share.
    * Revenue rose 4.7% to $108.64 million from a year ago;
analysts
expected $109.36 million. 
    * Ironwood Pharmaceuticals Inc's reported EPS for the
quarter was
28 cents​.
    * The mean earnings estimate of analysts had fallen by
about 13.8%
in the last three months.​ 
    * In the last 30 days there have been no negative revisions
of
earnings estimates 
    * Ironwood Pharmaceuticals Inc shares had risen by 5.8% this
quarter and lost 6.0% so far this year.
    * The company reported quarterly net income of $50.32
million.
    * Wall Street's median 12-month price target for Ironwood
Pharmaceuticals Inc is $13.50 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
3 at 01:33 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      0.27           0.28           Beat
 Jun. 30 2022      0.30           0.21           Missed
 Mar. 31 2022      0.26           0.21           Missed
 Dec. 31 2021      0.35           0.27           Missed